Intuitive Surgical (NASDAQ:ISRG) EVP Gary Loeb Sells 400 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Gary Loeb also recently made the following trade(s):

• On Wednesday, June 10th, Gary Loeb sold 400 shares of Intuitive Surgical stock. The stock was sold at an average price of $424.14, for a total value of $169,656.00.

Intuitive Surgical Stock Performance

ISRG stock traded up $14.57 during trading on Monday, reaching $393.38. 3,216,792 shares of the company traded hands, compared to its average volume of 2,458,957. The business has a 50 day simple moving average of $392.87 and a 200 day simple moving average of $445.15. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The company has a market capitalization of $138.97 billion, a price-to-earnings ratio of 45.06, a price-to-earnings-growth ratio of 2.74 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.81 earnings per share. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently modified their holdings of the company. Main Street Group LTD acquired a new stake in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Laurel Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth $31,000. Vermillion Wealth Management Inc. raised its holdings in shares of Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares during the last quarter. Turning Point Benefit Group Inc. lifted its position in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the period. Finally, Motiv8 Investments LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at $34,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on ISRG shares. Raymond James Financial restated an “outperform” rating and issued a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Sanford C. Bernstein reduced their price target on Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Bank of America decreased their price objective on Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Stifel Nicolaus lowered their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price on the stock. in a research report on Thursday, July 30th. Twenty investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $509.02.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.